Curious to see your top suppliers emissions?
Book a demo for a pilot project
Tissue Regenix Group plc
Pharmaceutical Preparation ManufacturingUnited Kingdom
Last verified 8 months agotissueregenix.com
Tissue Regenix Group plc, a pioneering name in regenerative medicine, is headquartered in the United Kingdom. Founded in 2006, the company has established itself as a leader in the development of innovative tissue regeneration technologies, primarily focusing on orthopaedics and wound care.
With a strong presence in Europe and North America, Tissue Regenix offers unique products such as dCELL® technology, which decellularises human and animal tissues to create scaffolds that promote natural healing. This approach not only enhances patient outcomes but also addresses the growing demand for effective regenerative solutions.
Recognised for its commitment to advancing medical science, Tissue Regenix has achieved significant milestones, positioning itself as a key player in the regenerative medicine industry. The company continues to drive innovation, making strides in both product development and market expansion.
21
DitchCarbon score
-19 vs industry average
Tissue Regenix Group plc’s score of 21 is lower than 42% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Tissue Regenix Group plc?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Medium
Pharmaceutical Preparation Manufacturing has typical carbon intensity
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Reported emissions
No reported emissions data is available for Tissue Regenix Group plc yet.
Tissue Regenix Group plc's reported carbon emissions
Tissue Regenix Group plc, headquartered in Great Britain, currently does not have available data on its carbon emissions, as indicated by the absence of specific figures in the latest emissions report. Consequently, there are no recorded Scope 1, Scope 2, or Scope 3 emissions totals to report.
Additionally, the company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments towards carbon footprint reduction at this time. Without specific emissions data or reduction initiatives, it is challenging to assess the company's climate impact or commitments within the industry context.
As the landscape of corporate sustainability continues to evolve, it will be important for Tissue Regenix Group plc to consider developing measurable climate commitments and strategies to align with industry standards and expectations.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Tissue Regenix Group plc’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Tissue Regenix Group plc yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisationsNo peer comparison is available for Tissue Regenix Group plc yet.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more